06.01.2013 Views

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

– 127 –<br />

Trends in Korean Animal <strong>Biotechnology</strong><br />

2003). The EPO protein has three N-glycosylation sites and one O-glycosylation site. N-glycosylation<br />

is considered the key player in the glycoprotein’s activity (Jelkmann, 1992). Not only<br />

the number but also the pattern of glycosylation seems important to the stability and activity of<br />

the protein. For example, instead of the normal three, Amgen’s new EPO product has five Nglycosylations<br />

to increase the half-life of the protein (Egrie and Browne, 2001).<br />

Table 1. World’s Top Biopharmaceutical Products (1996)<br />

Rank Product Company <strong>Business</strong> 1996 sales<br />

(USD<br />

1,000)<br />

1 Epogen Amgen Amgen 1,150<br />

2 Neupogen Amgen Amgen 1,017<br />

3 Procrit Amgen Ortho Biotech 995<br />

4 Humulin Genentech Eli Lilly 884<br />

5 Engerix-B Genentech SmithKline Beecham 568<br />

6 Intron A Biogen Schering-Plough 524<br />

7 Betaseron Chiron/Berlex Berlex/Schering AG 353<br />

8 Epivir BioChem Pharma/Glaxo Glaxo Wellcome<br />

Wellcome<br />

306<br />

9 Activase Genentech Genentech 284<br />

10 Humatrope Genentech/Eli Lilly Eli Lilly 268<br />

Total 6,348<br />

NLRI researchers have microinjected cloned transgene constructs into a one-celled embryo<br />

which was then transferred to a surrogate sow. The resulting piglets were identified by PCR<br />

using genomic DNA from each piglet’s tail. In 1998, a transgenic founder was identified out of<br />

47 candidate piglets using PCR and Southern blot analysis, both of which showed positive results<br />

<strong>for</strong> the founder individual. The founder was later named “Saerome,” meaning “novel one”<br />

in Korean. Trans<strong>for</strong>mation efficiency—the percentage of successful transgenic—was about 2%<br />

within progeny. The rate was lower, below 0.5%, if one success out of 204 transferred embryos<br />

was considered. Since 1999, a transgenic pig herd has been propagated. The gene transfer rate of<br />

the transgene reached 70% at F2 generation, as seen in Table 2.<br />

Table 2. Transfer Rate of the Transgene in Generations F1 through F3<br />

of a Transgenic Pig Herd<br />

Founder F1 F2 F3<br />

Number of transgenic individuals 1 82 30 34<br />

Gene transfer rate (%) 2.13 17.98 70.18 56.67<br />

The transgene now seems to have stabilized and is being inherited stably by the next generation.<br />

The sex ratio of progeny is about one to one, which suggests that the expression of the<br />

transgene does not inhibit survival of specific sexes during development. The milk from the<br />

transgenic female was examined. In this case study, one sow was milked after delivery <strong>for</strong> 50<br />

days during the lactation period, and about 880 units of human EPO were found in one milliliter<br />

of pig’s milk, about 8.8 grams per liter. The molecular weight <strong>for</strong> the EPO was about 34 kDa,<br />

similar to that of natural human EPO. The usual molecular weight of commonly used recombinant<br />

human EPO is about 50 kDa, which is a larger than natural EPO. After removal of glycosylation,<br />

this EPO showed the same molecular weight as commercial EPO that is identical to

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!